| Novo Nordisk A/S | 411.85 / -0.28% |
| Date/Time | 01/22 / 10:04 |
| Chg. / Chg.(%) | -1.15 / -0.28% |
| Bid | 411.85 / 182 |
| Ask | 412.00 / 62 |
| Open | 413.00 |
| Previous Close | 413.00 |
| High | 413.50 |
| Low | 409.80 |
| Volume [DKK] | 23,895,426.30 |
| Volume [Units] | 58,008 |
| Price fixings | 736 |
| ISIN | DK0060534915 |
| Security | NOVOB/C |
| Exchange | Cboe Europe CXE |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Turquoise | 411.85 |  |
68,600 |
| Cboe Europe .. | 411.85 | |
58,008 |
| Cboe Europe .. | 411.95 | |
33,575 |
| TradeGate | 55.11 | |
2,140 |
| London Inter.. | 411.65 | |
1,509 |
| Xetra | 55.12 | |
1,166 |
| Stuttgart | 55.230 | |
311 |
| Frankfurt | 55.1000 |  |
290 |
| Berlin | 55.05 | |
40 |
| Vienna Globa.. | 55.15 | |
0 |
| Düsseldorf | 55.00 | |
0 |
| München | 55.17 | |
0 |
| Hannover | 55.17 | |
0 |
| Hamburg | 55.17 | |
0 |
| Lang & Schwa.. | 55.08 | |
|
| gettex | 55.100 | |
|
| OMX Nordic | 412.90 | |
1,496,910 |
| Nasdaq Other.. | 61.6900 | |
15,818 |
| SIX Swiss Ex.. | 49.800 |
News
- French Regulatory Agency Agrees lacutamab TELLOMAK Trial Can Resume Recruitment in Sezary Syndrome and mycosis fungoides
01/13/2020 / 23:00 - GlobeNewswire - Virta Health Raises $93M to Combat the $400B Type 2 Diabetes Epidemic and Expand Diabetes Reversal to Millions
01/10/2020 / 14:00 - GlobeNewswire - Innate Pharma Provides Update from Regulatory Agencies on Lacutamab TELLOMAK Trial
01/09/2020 / 07:00 - GlobeNewswire - Aeterna Zentaris Receives NASDAQ Notification Regarding Minimum Bid Price Requirement
01/08/2020 / 22:01 - GlobeNewswire - BeyondSpring Strengthens Executive Rank for Pipeline Expansion and Commercialization Readiness in China
01/06/2020 / 14:00 - GlobeNewswire
Real-time